NEI
EW icon

Northwest & Ethical Investments’s Edwards Lifesciences EW Stock Holding History

Northwest & Ethical Investments’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$170K Sell
1,878
-27,345
-94% -$2.29M ﹤0.01% 433
2026
Q1 		$2.34M Sell
29,223
-7,414
-20% -$611K 0.05% 244
2025
Q4 		$3.12M Sell
36,637
-16,549
-31% -$1.36M 0.07% 230
2025
Q3 		$4.14M Buy
53,186
+1,180
+2% +$92.2K 0.1% 205
2025
Q2 		$4.07M Buy
52,006
+12,693
+32% +$947K 0.1% 201
2025
Q1 		$2.85M Sell
39,313
-35,995
-48% -$2.58M 0.08% 222
2024
Q4 		$5.58M Buy
+75,308
New +$5.27M 0.15% 175
2021
Q3 		– Sell
-13,354
Closed -$1.38M – 408
2021
Q2 		$1.38M Hold
13,354
– – 0.04% 274
2021
Q1 		$1.12M Hold
13,354
– – 0.04% 320
2020
Q4 		$1.22M Hold
13,354
– – 0.05% 305
2020
Q3 		$1.07M Buy
13,354
+6,112
+84% +$477K 0.05% 302
2020
Q2 		$500K Buy
+7,242
New +$515K 0.02% 341
2018
Q4 		– Sell
-1,875
Closed -$109K – 377
2018
Q3 		$109K Sell
1,875
-1,200
-39% -$58.7K 0.01% 329
2018
Q2 		$149K Hold
3,075
– – 0.01% 334
2018
Q1 		$143K Hold
3,075
– – 0.01% 335
2017
Q4 		$116K Buy
3,075
+900
+41% +$33K 0.01% 335
2017
Q3 		$79.2K Hold
2,175
– – ﹤0.01% 350
2017
Q2 		$85.7K Hold
2,175
– – 0.01% 352
2017
Q1 		$68.2K Sell
2,175
-141,600
-98% -$4.43M ﹤0.01% 367
2016
Q4 		$4.49M Sell
143,775
-5,325
-4% -$173K 0.31% 77
2016
Q3 		$5.99M Buy
149,100
+68,700
+85% +$2.59M 0.42% 54
2016
Q2 		$2.67M Buy
+80,400
New +$2.75M 0.2% 121

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Northwest & Ethical Investments's EW Position: Q2 2026 in Review

Northwest & Ethical Investments reduced its Edwards Lifesciences (EW) stake by 94% in Q2 2026, selling an estimated $2.29M and leaving 1,878 shares worth $170K. The position accounts for ﹤0.01% of the portfolio, ranked #433.

Northwest & Ethical Investments first reported a position in EW in Q2 2016 and has held it in 22 quarters since. The position peaked at $5.99M in Q3 2016. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Northwest & Ethical Investments held 1,878 shares of Edwards Lifesciences worth $170K as of Q2 2026.
  • Northwest & Ethical Investments sold 27,345 Edwards Lifesciences shares in Q2 2026, an estimated $2.29M.
  • Edwards Lifesciences made up ﹤0.01% of Northwest & Ethical Investments's portfolio in Q2 2026, its #433 holding.
  • Northwest & Ethical Investments first reported a position in Edwards Lifesciences in Q2 2016 and has held it in 22 quarters since.
  • Northwest & Ethical Investments's Edwards Lifesciences position peaked at $5.99M in Q3 2016.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Northwest & Ethical Investments's 13F filing for Q2 2026, filed 13 Aug 2026.